Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices 3197 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection 

(check justification or form 83): 

Extension with change of a currently 

approved collection. 

2. The Title of the Form/Collection: 

Records and Supporting Data: 

Importation, Receipt, Storage, and 

Disposition by Explosives Importers, 

Manufacturers, Dealers, and Users 

Licensed Under Title 18 U.S.C. Chapter 

40 Explosives. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form number (if applicable): None. 

Component: Bureau of Alcohol, 

Tobacco, Firearms and Explosives, U.S. 

Department of Justice. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Primary: Business or other for-profit. 

Other (if applicable): None. 

Abstract: This information collection 

requires the maintenance of records 

showing daily activities in the 

importation, manufacture, receipt, 

storage, and disposition of all explosive 

materials covered under 18 U.S.C. 

Chapter 40 Explosives. These records 

must also show where and to whom 

explosive materials are sent, thereby 

ensuring that any diversions will be 

readily apparent, and that ATF will be 

immediately notified if these materials 

are lost or stolen. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: An estimated 9,411 

respondents will prepare records for 

this information collection annually, 

and it will take each respondent 

approximately 12.6 hours to prepare the 

required records. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated annual public 

burden associated with this collection is 

592,893 hours, which is equal to 47,055 

(# of annual responses) * 12.6 (# of 

hours per response). 

7. An Explanation of the Change in 

Estimates: The adjustments associated 

with this collection include a decrease 

in the number of respondents, responses 

and total burden hours by 516, 2,580, 

and 32,508 hours respectively, since the 

last IC renewal in 2017. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405A, 

Washington, DC 20530. 

Dated: January 11, 2021. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2021–00743 Filed 1–13–21; 8:45 am] 

BILLING CODE 4410–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–768] 

Bulk Manufacturer of Controlled 

Substances Application: Siemens 

Healthcare Diagnostics Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siemens Healthcare 

Diagnostics Inc. has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 15, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 15, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 11, 2020, 

Siemens Healthcare Diagnostics Inc., 

100 GBC Drive, Mailstop 514, Newark, 

Delaware 19702–2461, applied to be 

registered as a bulk manufacturer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

code Schedule 

Ecgonine ....................... 9180 II 

The company plans to produce the 

listed controlled substance in bulk to be 

used in the manufacture of DEA exempt 

products. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00648 Filed 1–13–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–766] 

Bulk Manufacturer of Controlled 

Substances Application: IsoSciences, 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: IsoSciences, LLC has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTAL

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 15, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 15, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 11, 2020, 

IsoSciences, LLC, 340 Mathers Road, 

Ambler, Pennsylvania 19002–3420, 

applied to be registered as an bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Cathinone ................................ 1235 I 

Methcathinone ........................ 1237 I 

Lysergic acid diethylamide ..... 7315 I 

Marihuana ............................... 7360 I 


khammond on DSKJM1Z7X2PROD with NOTICES
3198 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ........... 7370 I 

3,4-Methylene

dioxyamphetamine.

7400 I 

3,4-Methylenedioxy-Nethylamphetamine.7404 I 

3,4-Methylene

dioxymethamphetamine.

7405 I 

5-Methoxy-N–Ndimethyltryptamine.7431 I 

Alpha-methyltryptamine .......... 7432 I 

Bufotenine ............................... 7433 I 

Diethyltryptamine .................... 7434 I 

Dimethyltryptamine ................. 7435 I 

Psilocybin ................................ 7437 I 

Psilocyn ................................... 7438 I 

5-Methoxy-N,Ndiisopropyltryptamine.7439 I 

Dihydromorphine ..................... 9145 I 

Heroin ..................................... 9200 I 

Nicocodeine ............................ 9309 I 

Nicomorphine .......................... 9312 I 

Normorphine ........................... 9313 I 

Thebacon ................................ 9315 I 

Normethadone ........................ 9635 I 

Acryl fentanyl (N-(1- 

phenethylpiperidin-4-yl)-Nphenylacrylamide).

9811 I 

Para-Fluorofentanyl ................ 9812 I 

3-Methylfentanyl ...................... 9813 I 

Alpha-methylfentanyl .............. 9814 I 

Acetyl-alpha-methylfentanyl .... 9815 I 

N-(2-fluorophenyl)-N-(1- 

phenethylpiperidin-4- 

yl)propionamide.

9816 I 

Acetyl Fentanyl (N-(1- 

phenethylpiperidin-4-yl)-Nphenylacetamide).

9821 I 

Butyryl Fentanyl ...................... 9822 I 

4-Fluoroisobutyryl fentanyl (N- 

(4-fluorophenyl)-N-(1- 

phenethylpiperidin-4- 

yl)isobutyramide).

9824 I 

2-methoxy-N-(1- 

phenethylpiperidin-4-yl)-Nphenylacetamide.

9825 I 

Beta-hydroxyfentanyl .............. 9830 I 

Beta-hydroxy-3-methylfentanyl 9831 I 

Alpha-methylthiofentanyl ......... 9832 I 

3-Methylthiofentanyl ................ 9833 I 

Furanyl fentanyl (N-(1- 

phenethylpiperidin-4-yl)-Nphenylfuran-2-carboxamide).

9834 I 

Thiofentanyl ............................ 9835 I 

Beta-hydroxythiofentanyl ........ 9836 I 

N-(1-phenethylpiperidin-4-yl)- 

N-phenyltetrahydrofuran-2- 

carboxamide.

9843 I 

Amphetamine .......................... 1100 II 

Methamphetamine .................. 1105 II 

Codeine ................................... 9050 II 

Dihydrocodeine ....................... 9120 II 

Oxycodone .............................. 9143 II 

Hydromorphone ...................... 9150 II 

Hydrocodone ........................... 9193 II 

Isomethadone ......................... 9226 II 

Methadone .............................. 9250 II 

Methadone intermediate ......... 9254 II 

Morphine ................................. 9300 II 

Thebaine ................................. 9333 II 

Levo-alphacetylmethadol ........ 9648 II 

Oxymorphone ......................... 9652 II 

Thiafentanil ............................. 9729 II 

Alfentanil ................................. 9737 II 

Sufentanil ................................ 9740 II 

Carfentanil ............................... 9743 II 

Fentanyl .................................. 9801 II 

The company plans to manufacture 

bulk controlled substances for use in 

analytical testing. In reference to drug 

codes 7360 (Marihuana) and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetics. No other activities for 

these drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00647 Filed 1–13–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1121–0269] 

Agency Information Collection 

Activities: Proposed Collection; 

Comments Requested; Reinstatement, 

With Change, of a Previously 

Approved Collection for Which 

Approval Has Expired: 2020 Census of 

Publicly Funded Forensic Crime 

Laboratories (CPFFCL) 

AGENCY: Bureau of Justice Statistics, 

Department of Justice. 

ACTION: 60-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Office of Justice Programs, 

Bureau of Justice Statistics, will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until March 

15, 2021. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Connor Brooks, Statistician, Law 

Enforcement Statistics Unit, Bureau of 

Justice Statistics, 810 Seventh Street 

NW, Washington, DC 20531 (email: 

Connor.Brooks@usdoj.gov; phone: 202– 

514–8633). 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Reinstatement of the Census of Publicly 

Funded Forensic Crime Laboratories, 

with changes, of a previously approved 

collection for which approval has 

expired. 

(2) The Title of the Form/Collection: 

2020 Census of Publicly Funded 

Forensic Crime Laboratories. 

(3) The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

The form number is CFCL–20. The 

applicable component within the 

Department of Justice is the Bureau of 

Justice Statistics, Office of Justice 

Programs. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

This information collection is a 

census of federal, state, and local 

publicly funded forensic crime 

laboratories that analyze criminal 

evidence. This data collection follows 

the 2014 study and will collect 

information on personnel, budgets, 

workloads, policies, and procedures of 

crime laboratories. BJS plans to field the 

2020 CPFFCL from May to October 

2021. The census form was assessed by 

practitioners and subject matter experts 

to update it from the 2014 form and 

ensure its relevance to forensic crime 

laboratories as well as reduce 

respondent burden. The form was then 

cognitively tested with 23 forensic 

crime laboratories of different sizes, 

regions, and government levels. In 

addition to collecting detailed data for 

the 2020 reference year, CPFFCL will 

also collect summary data for the 2019 

reference year. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: A projected 500 respondents 

will take an average of 2.5 hours each 

to complete form, including time to 

research or find information not readily 


khammond on DSKJM1Z7X2PROD with NOTICES